Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Patient Preference Study Survey Opportunity

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

CLL Society is collaborating with RTI-Health Solutions (RTI-HS), a non-profit research organization in North Carolina, to learn about the perspectives and treatment preferences of individuals with Chronic Lymphocytic Leukemia (CLL). The study is being conducted on behalf of a pharmaceutical company to ensure that new treatments best reflect patients’ needs.

CLL patients may be eligible to take part in this online survey. Our goal is to learn more about the aspects of treatment that matter most to patients with CLL. Make your voice heard about your treatment priorities by taking part.

Eligible participants will be paid for completing the 30-minute online survey. If you are interested in participating or would like to receive further information about the study, please click here: CLL Screener. You will be required to enter your email and phone number to be screened for eligibility.

If you have any questions about this survey, please contact Global Perspectives at